J. Goldman & CO LP Merck & Co., Inc. Call Options Transaction History

J. Goldman & CO LP

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$123.8 - $132.96 $4.99 Million - $5.36 Million	40,300 Added 67.5%	100,000 $12.4 Million
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $6.32 Million - $7.36 Million	-55,800 Reduced 48.31%	59,700 $7.88 Million
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $5.06 Million - $5.51 Million	50,500 Added 77.69%	115,500 $12.6 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $6.69 Million - $7.43 Million	65,000 New	65,000 $6.69 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $13.9 Million - $15.5 Million	135,000 New	135,000 $14.4 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $6.34 Million - $7.12 Million	75,000 New	75,000 $6.46 Million
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $9.23 Million - $11.6 Million	-127,700 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $9.15 Million - $10.1 Million	127,700 New	127,700 $9.59 Million
Q4 2020 Feb 16, 2021	SELL	$71.77 - $79.65 $7.41 Million - $8.23 Million	-103,300 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$73.18 - $82.95 $7.56 Million - $8.57 Million	103,300 New	103,300 $8.57 Million

3,815

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $249B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.